Stefan Sperl
Executive Vice President of CMC & OperationsDr. Stefan Sperl, Ph.D. is an Executive Vice President of CMC and Operations at Kiora Pharmaceuticals, Inc. He co-founded Panoptes Pharma GES.M.B.H and served as its Chief Operating Officer. Prior to this position, Dr. Sperl served as Global Project Manager at Nabriva Therapeutics AG, responsible for all development programs ranging from early preclinical to clinical phase 2 programs. Before that, he headed the project management at Biovertis AG and was responsible for the internal and external drug discovery programs with emphasis on structure-based hit-to-lead optimizations. From 2000 to 2005, Dr. Sperl headed the small molecule research unit at Wilex AG, where he was responsible for lead optimization and GMP production. He has invented several patents of small molecules currently in clinical development. Dr. Sperl received his PhD in Chemistry from the Max Planck Institute in Martinsried, Germany in 2000.
Positions
- Company NameKiora Pharmaceuticals, Inc.Stock CodeKPRXPositionExecutive Vice President of CMC & OperationsColleagues
- BMBrian M. StremPresident, CEO & Director
- PTPraveen TyleIndependent Chairman of the Board
- MTMelissa ToscaChief Financial Officer
- KJKeith J. LaneExecutive VP and Head of Clinical Development & Regulatory Affairs
- DADavid A. HollanderIndependent Director
- EPErin ParsonsNon-Employee Independent Director
- LWLisa Walters-HoffertIndependent Director
